STOCK TITAN

Precision Optics grants director 30,000 stock options

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Precision Optics Corporation, Inc. (POCI) director Duncan Buell received 30,000 stock options on November 18, 2026, exercisable for 30,000 common shares. The options have a $4.18 per-share exercise price and expire November 18, 2036. They vest in four equal installments on December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027, subject to Buell remaining continuously employed by the company through each applicable date. The grant was made under the company’s 2022 Equity Incentive Plan.

Insider Duncan Buell
Role Director
Type Security Shares Price Value
Grant/Award Stock Options (Rights to buy) F1 30,000 $0.00 $0.00
Holdings After Transaction: Stock Options (Rights to buy) — 30,000 options (Direct)
Footnotes (1)
  1. F1. The options vest in four equal installments on December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
Stock options granted 30,000 options Granted November 18, 2026; exercisable for 30,000 common shares
Exercise price $4.18 per share For the options granted November 18, 2026
Vesting schedule 4 equal installments December 30, 2026; March 30, 2027; June 29, 2027; September 29, 2027, subject to continuous employment through each applicable date
Option expiration November 18, 2036 Options granted November 18, 2026
vest in four equal installments financial
"The options vest in four equal installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many stock options did a Precision Optics (POCI) director receive?

Duncan Buell, a director, received 30,000 stock options, exercisable for 30,000 common shares, with a $4.18 per-share exercise price.

When do Duncan Buell’s POCI options vest?

The options vest in four equal installments on December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027, subject to Buell remaining continuously employed through each applicable date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duncan Buell

(Last)(First)(Middle)
C/O PRECISION OPTICS CORPORATION,INC.
550 KING STREET, BLDG. A, STE. 100

(Street)
LITTLETON MASSACHUSETTS 01460

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECISION OPTICS CORPORATION, INC. [ POCI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Rights to buy)$4.1811/18/2026A30,000 (1)11/18/2036Common Stock30,000$030,000D
Explanation of Responses:
1. The options vest in four equal installments on December 30, 2026, March 30, 2027, June 29, 2027, and September 29, 2027, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
/s/ Joseph N. Forkey as attorney-in-fact11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading